These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15990964)

  • 1. Prognostic value of thymidine phosphorylase activity in liver tissue adjacent to hepatocellular carcinoma.
    Ezaki T; Ikegami T; Maeda T; Yamada T; Ishida T; Hashizume M; Maehara Y
    Int J Clin Oncol; 2005 Jun; 10(3):171-6. PubMed ID: 15990964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of thymidine phosphorylase in HCC with chronic liver disease for long-term postoperative recurrence.
    Ezaki T; Ikegami T; Ishida T; Aimitsu S; Mori M; Fujihara M
    J Surg Oncol; 2003 Jul; 83(3):173-9; discussion 179. PubMed ID: 12827687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas.
    Ikeguchi M; Sakatani T; Ueda T; Hirooka Y; Kaibara N
    In Vivo; 2001; 15(4):265-70. PubMed ID: 11695216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of thymidine phosphorylase activity in hepatocellular carcinoma and chronic diseased livers: a special reference to liver fibrosis and multicentric tumor occurrence.
    Shimada M; Hasegawa H; Rikimaru T; Gion T; Hamatsu T; Yanashita Y; Shirabe K; Sugimachi K
    Cancer Lett; 2000 Feb; 148(2):165-72. PubMed ID: 10695993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in hepatocellular carcinoma and metastatic liver cancer.
    Hotta T; Kobayashi Y; Taniguchi K; Johata K; Sahara M; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
    Oncol Rep; 2004 Aug; 12(2):347-51. PubMed ID: 15254700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma.
    Huang SF; Wu HD; Chen YT; Murthy SR; Chiu YT; Chang Y; Chang IC; Yang X; Loh YP
    Tumour Biol; 2016 Jul; 37(7):9745-53. PubMed ID: 26803519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.
    Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K
    J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
    Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
    World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum WFA+ -M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Korenaga M; Mizokami M; Narimatsu H
    Liver Int; 2016 Feb; 36(2):293-301. PubMed ID: 26134114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
    Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of E-cadherin and vascular endothelial growth factor in noncancerous liver is associated with recurrence of hepatocellular carcinoma after curative resection.
    Minata M; Kudo M; Harada KH; Ikai I; Nishida N
    Oncology; 2013; 84 Suppl 1():88-92. PubMed ID: 23428865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxiredoxin 1, restraining cell migration and invasion, is involved in hepatocellular carcinoma recurrence.
    Fang Y; He J; Janssen HLA; Wu J; Dong L; Shen XZ
    J Dig Dis; 2018 Mar; 19(3):155-169. PubMed ID: 29377617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity in tumor and remnant liver as predictor of recurrence and survival in hepatocellular carcinoma after resection.
    Shan YS; Hsieh YH; Lin PW
    World J Surg; 2007 May; 31(5):1121-8. PubMed ID: 17429564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear PKM2 expression, an independent risk factor for ER after curative resection of hepatocellular carcinoma.
    Fan F; Wu H; Liu Z; Hou X; Chen W; Wang A; Lu Y
    Biomed Pharmacother; 2016 Dec; 84():1858-1864. PubMed ID: 27894667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
    Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
    Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy.
    Ha SY; Paik YH; Yang JW; Lee MJ; Bae H; Park CK
    Gut Liver; 2016 Sep; 10(5):826-35. PubMed ID: 27282266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels.
    Huang G; Lau WY; Zhou WP; Shen F; Pan ZY; Yuan SX; Wu MC
    JAMA Surg; 2014 Jun; 149(6):519-27. PubMed ID: 24696192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.